Rapid radiosynthesis of two [18F]-labeled nicotinamide derivatives for malignant melanoma imaging

Appl Radiat Isot. 2018 Feb:132:142-146. doi: 10.1016/j.apradiso.2017.12.004. Epub 2017 Dec 5.

Abstract

The rapid synthesis of two radiofluoronicotinamide derivatives, namely, [18F]MEL050 and [18F]MEL-2F has been simply performed starting from commercial materials. [18F]MEL-2F is a new, potential analogue PET-probe for melanoma imaging. [18F]MEL050 is already an excellent PET imaging probe for early specific diagnosis. The synthesis involves coupling step to obtain the precursor followed by radiofluorination. During the synthesis of the precursors different coupling reagents, such as HBTU, TFFH, HOBT, COMU and PyCIU have been applied. PyClU was found the best to reduce the coupling period to < 1h. The labeled compounds were isolated and purified by HPLC. In the in-vitro study three kinds of cells, namely, Melur (melanin free), KB-3 carcinoma cell line (non-melanoma) and B16-F10 melanoma cell line were used to evaluate the uptake of the radiotracers.

Keywords: Coupling agent; MEL050; Melanoma imaging probe; [(18)F]N-(2-diethylammino-ethyl)-2,6-difluoropyridine-3-carboxamide ([(18)F]MEL-2F).

MeSH terms

  • Animals
  • Carbon-13 Magnetic Resonance Spectroscopy
  • Cell Line, Tumor
  • Chromatography, High Pressure Liquid
  • Fluorine Radioisotopes / chemistry*
  • Fluorine Radioisotopes / pharmacokinetics
  • Indicators and Reagents / chemistry
  • Mass Spectrometry
  • Melanoma, Experimental / diagnostic imaging*
  • Melanoma, Experimental / metabolism
  • Melanoma, Experimental / pathology
  • Mice
  • Niacinamide / chemical synthesis*
  • Niacinamide / chemistry
  • Niacinamide / pharmacokinetics
  • Proton Magnetic Resonance Spectroscopy
  • Radiopharmaceuticals / chemistry*
  • Radiopharmaceuticals / pharmacokinetics

Substances

  • Fluorine Radioisotopes
  • Indicators and Reagents
  • Radiopharmaceuticals
  • Niacinamide
  • Fluorine-18